Showing 11 posts of 221 posts found.

J&J post modest second quarter increase

July 21, 2010
Sales and Marketing 2010 financials, J&J, JJ, Q2

Johnson & Johnson has seen a modest increase in sales for the second quarter, buoyed primarily by international sales and …

J&J cited by FDA for another manufacturing facility

July 20, 2010
Manufacturing and Production J&J, JJ, manufacturing compliance

Another week, another raft of bad news for Johnson & Johnson’s manufacturing division. With one production facility already shut down …

J&J faces FDA scrutiny for another manufacturing unit

May 27, 2010
Manufacturing and Production Advanced Sterilization Products, Ethicon, J&J, JJ, McNeil, manufacturing compliance

Another Johnson & Johnson subsidiary has come under scrutiny by FDA for failing to meet quality standards in its manufacturing. …

Pharma mergers and acquisitions in 2009

December 22, 2009
Research and Development, Sales and Marketing Abbott, GSK, J&J, JJ, M&A, MA, Novartis, Pfizer, Wyeth, generics, industry, merger, year in review

This year saw two ‘mega mergers’ in the sector, the acquisition of Wyeth by Pfizer and the reverse takeover of …

J&J continues streamlining by cutting managers

November 11, 2009
Sales and Marketing JJ, restructure

 Johnson & Johnson has announced further restructuring that will see more than 8,000 jobs being cut.The conglomerate says that it …

Johnson & Johnson rides out patent attack

October 16, 2009
Sales and Marketing JJ, generics

 Profits at Johnson & Johnson have risen in the third quarter, despite deep cuts into pharma sales caused by new …

J&J buys stake in vaccines firm Crucell

September 29, 2009
Sales and Marketing Crucell, JJ, vaccines

Johnson & Johnson has acquired an 18% stake in Netherlands-based vaccines firm Crucell, and the two companies will work together …

Janssen-Cilag wins NICE approval for psoriasis drug Stelara

September 23, 2009
Sales and Marketing JJ, NICE, Stelara

 NICE has approved Janssen-Cilag’s Stelara as a treatment option for adults with moderate to severe plaque psoriasis.Part of the process …

Johnson & Johnson to buy Cougar Biotechnology

May 27, 2009
Research and Development, Sales and Marketing Cougar, J&J, JJ

Johnson & Johnson is to buy Los Angeles-based biotech firm Cougar Biotechnology for $970 million.The purchase, expected to go through …

Simponi approved in Canada

April 16, 2009
Research and Development, Sales and Marketing J&J, JJ, Simponi

Johnson & Johnson's monoclonal antibody Simponi has been given regulatory approval in Canada.Simponi (golimumab) has been given the green light …

Johnson & Johnson appoints new global pharma chair

October 14, 2008
Sales and Marketing JJ

Johnson & Johnson has named a new chairman for its struggling pharmaceuticals group, and kept the role under female leadership. …

Latest content